Layer 1

Pharmacy2U: New dispensing hub 'working smoothly'

Pharmacy2U: New facility will increase capacity by factor of 10

The online pharmacy business is "very confident" in the £3.5 million facility, which was responsible for delivery problems last December

Pharmacy2U says its new prescription hub is now “working smoothly”, despite the initial move to the facility preventing it from delivering medication over Christmas.

The move to the "state of the art prescription fulfillment facility" in December meant the online pharmacy business was unable to deliver any prescriptions from December 21 to January 11. But managing director Daniel Lee told C+D yesterday (May 4) that he is “very confident” in the new hub’s “future performance”.

The company officially unveiled its £3.5 million Leeds hub yesterday. The facility will enable the company to dispatch over 1m items per month – more than 10 times the capacity of Pharmacy2U's previous system – it said.

Additional capacity for pharmacies

The hub can be used to provide "additional capacity" for high street pharmacies as well as supporting Pharmacy2U's own over-the-counter, private prescription and online doctor services, it added.

The "bold new investment" in the hub is part of Pharmacy2U's "long and proud history of innovation", said Mr Lee.

Last month, the General Pharmaceutical Council (GPhC) would not confirm to C+D whether it will discuss Pharmacy2U's Christmas delivery disaster as part of its fitness-to-practise hearings against Mr Lee and Pharmacy2U's commercial director Julian Harrison. The regulator has only revealed that the hearing later this month (May 23-25) will assess Pharmacy2U's sale of patient data to a third-party marketing company 


How successful do you think Pharmacy2U's new hub will be?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information


S Morein, Pharmacy Area manager/ Operations Manager

Despite a massive investment P2U can only manage 12m items annually. With a billion items annually being prescribed at maximum capacity they are not even statistically significant.


M Elnemy, Non healthcare professional

Morein....its the gross profit that matters at the end of the day........with time more and more ppl will use online pharmacies

M Elnemy, Non healthcare professional

Sounds like some ppl are jeleous 

I'm not a fan of online pharmacies as I genuinely feel it's better to have face to face contact with customers BUT what it has done is given a kick up the backside to the big three


they can no longer take ppl for granted. 

Saw an advert in the [email protected]


good luck to them. Anything that takes busines away from multiples is a good thing 

Alan WHITEMANN, Communications

Better still, take the services off them. ( for abuse )

Harry Tolly, Pharmacist

Have you noted the recent announcement by His Royal Excellency, "The Chief Pharmaceutical Officer for England" stating that he wants to put a different mechanism in place for renumerating online pharmacies.  By hook or crook, the DoH wants the multiples to have monopoly on the supply of medicines in the UK. Every single policy decision is pointing towards that end goal.

Mr Pharmacist!, Pharmaceutical Adviser

The problem that innovative companies face will be always dealing with grey issues.  Although they sold patient data, you really need to look at the NHS as a whole.  Yesterday I read that some NHS trusts are overtly selling patient data to GOOGLE!!!  Thats mind blowing.  They say that the data is theirs implicity and they can do what they like.  Its up to people to question the ethics of this, but I feel that there is so much apathy, most people dont give a crap.  Furthermore, its mainly contractors on boards like this that whinge and moan, but I think that's more to do with the success of P2U's model rather than anything remotely nobel.

Chris Cairns, Academic pharmacist

These NHS Trusts are not doing the same as Pharmacy2U who simply passed on a bundle of personally identifiable patient data to a marketing company for financial gain in contravention of the Data protection Act. And goodness knows how many professional ethical standards. The NHS Trusts are sending anonymous data to an arm of Google that analyses data to find trends in biological markers such as laboratory tests and diagnoses to be able identify future disease risk factors and likely occurence of disease. This arm of Google has the computing power to do this. The data is supplied only for this purpose, and the NHS Trusts involved are probably paying Google for these analyses. The results then help the Trusts to look after their patients better as well as generate important data to inform current and future delivery of health care. Hardly the same as P2U flogging patient details to a marketing company for cash.


Mr Pharmacist!, Pharmaceutical Adviser

Chris, stop peddling utter nonsense.  Data is being sold including high personal information....

Chris Cairns, Academic pharmacist

Read the article fully. Here are some quotes from it. And do remember it is the Daily Mail and not a peer reviewed publication of high provenance

'The trust said that the data will not be sold on, adding in an online Q&A: 'Patients can opt out of any data-sharing system that the Royal Free London uses by contacting the trust’s data protection officer'.'

'Imperial College Healthcare NHS Trust admitted it was also in talks with Google over a deal - this time for an app to alert staff to hospital patients at risk of deterioration through kidney failure.'

'But bosses at St Mary's in Paddington, one of the hospitals overseen by the Trust, say that no patient records have been handed over to DeepMind - Google's secretive artificial intelligence arm.' 

'The Royal Free insisted it did not sell the files to Google and no money changed hands. The trust, which includes three London hospitals, and Google say the data is encrypted, will be processed by only a computer program, and there is no chance of it being leaked online.'

I have no problem with discussing things in an informed evidence based manner, so I do not 'peddle utter nonsense'. Read the article, and yes there are some things that could be of concern but none of them meet the P4U breach of the DPA of selling patient identifiable information to a market research organisation for a financial gain.



Harry Tolly, Pharmacist

How long before it is bought out by one of the vertically integrated wholesalers ? That would logically be the exit route for the early investors in P2U. AND given that it is in a different model of operation to the High Street there would be little by way of Competition issues.



Maybe a group of independents could raise the cash and do something similar ? Not rocket science, just skillset deployment.

Job of the week

Pharmacist Manager
Midlands, Cheshire & Dorset
Salary dependent upon experience